708 completed, 169 unknown, 157 terminated, 154 recruiting. 511 Phase 2, 267 Not applicable, 250 Phase 1, 161 Phase 3, 74 Phase 4.
Follow Graft vs Host Disease: new trials by email Literature Review of Graft vs Host Disease trials Research Report on Graft vs Host Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Mindfulness Intervention to Reduce Patient Reported Symptoms in Patients With Chronic Graft-Versus-Host Disease Biospecimen Collection, Mindfulness Relaxation, Survey Administration - Chronic Graft Versus Host Disease, Hematopoietic and Lymphatic System Neoplasm | Not applicable | Recruiting | City of Hope Medical Center | 17 | 2027-03-01 | 2026-10-16 |
| CD34+ Enriched Transplants to Treat Myelodysplastic Syndrome Busulfan, Melphalan, Fludarabine - Myelodysplastic Syndromes, Graft Vs Host Disease | Not applicable | Not yet recruiting | Guenther Koehne | 62 | 2027-01-01 | 2026-10-13 |
| CSF-1R Inhibitor, Axatilimab, for Prevention of Acute and Chronic GVHD After HLA-Matched Related and Unrelated Donor Allogeneic Stem Cell Transplantation Hematopoietic Cell Transplantation, Cyclophosphamide, Tacrolimus - Graft -Versus-host-disease | Phase 2 | Not yet recruiting | Medical College of Wisconsin | 72 | 2026-11-01 | 2026-09-08 |
| Emerging Indications for Hyperbaric Oxygen Treatment Hyperbaric oxygen treatment (HBOT), 100% Oxygen - Post-COVID-19 Condition, Ulcerative Colitis | Phase 4 | Not yet recruiting | Jay C. Buckey Jr. | 100 | 2026-11-01 | 2026-09-09 |
| Vitamin C With Steroids for Gastrointestinal GVHD Vitamin C (Ascorbic Acid) - Graft-versus-host-disease (GVHD), Gastrointestinal | Early Phase 1 | Not yet recruiting | Baylor College of Medicine | 35 | 2026-11-01 | 2026-10-13 |
| Kinetic Analysis of Immune Cells in Blood and Chronic Graft-Versus-Host Disease-Affected Tissues After Allogeneic Hematopoietic Cell Transplantation Non-Interventional Study - Graft Versus Host Disease, Hematopoietic and Lymphatic System Neoplasm | Recruiting | City of Hope Medical Center | 75 | 2026-11-01 | 2026-10-05 | |
| CK0802 for Treatment of Steroid Refractory Graft vs. Host Disease (GVHD) CK0802 (Allogeneic, Cryopreserved, Cord blood-derived T-regulatory cells, cells that are not HLA matched) - Steroid Refractory Graft Versus Host Disease | Phase 1 / Phase 2 | Not yet recruiting | Cellenkos, Inc. | 12 | 2026-11-01 | 2026-10-21 |
| Nutritional Intervention for Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation Enteral Nutritional Suspension (TP-MCT), Routine nutritional guidance, Biospecimen-Stool Sample Collection - Hematopoietic Stem Cell Transplantation (HSCT), Malnutrition (Calorie) | Not applicable | Not yet recruiting | Institute of Hematology & Blood Diseases Hospital, China | 160 | 2026-10-12 | 2026-09-30 |
| Use of Bone Marrow Stem Cells (MesenCell) for the Treatment of Patients With Chronic Graft-versus-host Disease Mesenchymal Stem Cell Infusion - Graft vs Host Disease, Mesenchymal Stem Cell Transplantation | Phase 1 | Not yet recruiting | Pontifícia Universidade Católica do Paraná | 20 | 2026-10-01 | 2026-09-17 |
| Sirolimus+Ruxolitinib+Mycophenolate Mofetil for Prophylaxis of aGVHD in Patients Receiving Haplo-HSCT Who Are Intolerant to CNI Sirolimus, Ruxolitinib, MMF - Acute Leukemia, Myelodysplastic Syndromes | Phase 1 / Phase 2 | Not yet recruiting | Peking University People's Hospital | 40 | 2026-10-01 | 2026-09-09 |
| Evaluation of Allogenic Mesenchymal Stem Cell (MSC) Injection Therapy for Refractory Graft-versus-Host Disease (GVHD) Unresponsive to Conventional Treatments Subconjuntival injection of expanded allogenic adult adipose tissue-derived mesenchymal stem cells (ASC - Dry Eye Disease (DED), Graft-Versus-Host Disease(GVHD) | Phase 2 | Not yet recruiting | Instituto de Investigación Biomédica de Salamanca | 30 | 2026-10-01 | 2026-09-03 |
| Evaluating the Effects of Propionate and Butyrate Supplementation on the Intestinal Health of Healthy Volunteers Biospecimen Collection, Microencapsulated Sodium Butyrate, Microencapsulated Sodium Propionate - Graft Versus Host Disease, Hematopoietic and Lymphatic System Neoplasm | Phase 1 | Not yet recruiting | City of Hope Medical Center | 12 | 2026-09-30 | 2026-05-28 |
| A Preliminary Clinical Study on the Efficacy of Cyclophosphamide and Sirolimus Combined With VIC-1911 in Preventing Graft-versus-Host Disease After Haploidentical Stem Cell Transplantation in Children 1mg /kg VIC-1911 - GVHD (Acute or Chronic) | Phase 1 | Recruiting | Shanghai Jiao Tong University School of Medicine | 9 | 2026-09-28 | 2026-10-20 |
| FMT for Pediatric SR-aGVHD Fecal Microbial Transplantation - Acute Graft Versus Host Disease in Intestine | Phase 1 / Phase 2 | Recruiting | Bambino Gesù Hospital and Research Institute | 20 | 2026-09-17 | 2026-10-20 |
| A Study to Investigate the Efficacy and Safety of Belumosudil Compared With Best Available Therapy in Participants Aged 12 Years or Older With Chronic Graft-versus-host Disease Belumosudil, Best available therapy (BAT) - Chronic Graft Versus Host Disease | Phase 3 | Not yet recruiting | Sanofi | 356 | 2026-09-07 | 2026-09-15 |
| A Multicentre Randomised Controlled Trial Evaluating the Efficacy of the SMILE™ Module for Improving Short-term Periodontal Outcomes, Compliance, and Acceptability Among Clinical Dental Students SMILE Module, Conventional Toothbrushing Module - Gingivitis, Gingivitis; Chronic | Not applicable | Not yet recruiting | National University of Malaysia | 66 | 2026-09-01 | 2026-07-15 |
| A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase III Trial of Remestemcel-L-rknd Added to Ruxolitinib for Grade III-IV Steroid-Refractory Acute Graft-Versus-Host Disease Remestemcel-L-rknd, Placebo - GVHD - Graft-Versus-Host Disease | Phase 3 | Not yet recruiting | Mesoblast, Ltd. | 180 | 2026-08-31 | 2026-05-05 |
| Efficacy of Bee Venom Phonophoresis in Treating Chronic Sinusitis: Bee Venom Phonophoresis, Standard Care (oral decongestants + saline nasal irrigation) - Chronic Sinusitis, Acute Sinusitis | Not applicable | Not yet recruiting | Sinai University | 30 | 2026-08-15 | 2026-08-04 |
| A Study to Investigate Safety of Belumosudil in Participants Aged 12 Years and Above, With Chronic Graft-versus-host Disease (cGVHD) Belumosudil - Chronic Graft Versus Host Disease | Phase 4 | Not yet recruiting | Sanofi | 26 | 2026-08-10 | 2026-05-12 |
| Study to Compare the Plasma Concentration of Belumosudil Given as an Oral Suspension and as a Tablet to Healthy Adult Male Participants Belumosudil - Chronic Graft Versus Host Disease | Phase 1 | Not yet recruiting | Sanofi | 58 | 2026-08-06 | 2026-07-24 |
Showing 20 of 1350. Sign in to see all of them.
Bronchiolitis Obliterans Syndrome (703) · Leukemia (138) · Myelodysplastic Syndromes (119) · Leukemia, Myeloid, Acute (103) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (103) · Hematologic Neoplasms (87) · Leukemia, Lymphocytic, Chronic, B-Cell (83) · Lymphoma (74) · Lymphoma, Non-Hodgkin (68) · Lymphoma, Follicular (67) · Multiple Myeloma (64) · Hodgkin Disease (62) · Myeloproliferative Disorders (53) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (52)
Immune System Diseases (1332) · Lung Diseases (709) · Respiratory Tract Diseases (709) · Lung Diseases, Obstructive (706) · Bronchial Diseases (705) · Bronchiolitis (705) · Bronchitis (703) · Organizing Pneumonia (702) · Bronchiolitis Obliterans (685) · Pathological Conditions, Signs and Symptoms (439) · Hemic and Lymphatic Diseases (355) · Hematologic Diseases (314) · Neoplasms (301) · Pathologic Processes (276)
Tacrolimus (98) · Cyclophosphamide (94) · Mycophenolic Acid (70) · Sirolimus (67) · Cyclosporine (66) · Methotrexate (65) · Busulfan (45) · Antilymphocyte Serum (42) · Methylprednisolone (41) · fludarabine phosphate (41) · fludarabine (40) · Prednisone (32) · ruxolitinib (32) · Rituximab (29) · Filgrastim (25)
Fred Hutchinson Cancer Center (33) · Dana-Farber Cancer Institute (29) · National Heart, Lung, and Blood Institute (NHLBI) (29) · Novartis Pharmaceuticals (26) · M.D. Anderson Cancer Center (24) · National Cancer Institute (NCI) (22) · Incyte Corporation (17) · H. Lee Moffitt Cancer Center and Research Institute (15) · Assistance Publique - Hôpitaux de Paris (14) · City of Hope Medical Center (13) · Hoffmann-La Roche (12) · Massachusetts General Hospital (12) · Karolinska Institutet (10) · National Institute of Allergy and Infectious Diseases (NIAID) (10) · AstraZeneca (9)
United States (673) · France (106) · Germany (99) · China (95) · Canada (93) · Italy (90) · Spain (79) · United Kingdom (78) · Belgium (61) · Australia (49) · Israel (46) · South Korea (45) · Netherlands (40) · Turkey (Türkiye) (39) · Poland (36)
Stephanie Lee (7) · A. John Barrett, M.D. (6) · Amin Alousi, MD (6) · Michael Y Shapira, MD (6) · Pooja Khandelwal, MD (6) · Amandeep Salhotra (4) · Barbara Jean Bambach, MD (4) · Christopher James, PA (4)
PMID 23065508, PMID 23524640, PMID 32816215, PMID 29316837, PMID 32160294, PMID 36240296, PMID 42133908, PMID 16551963, PMID 19282026, PMID 20965785, PMID 23802653, PMID 23861248, PMID 24432712, PMID 25287629, PMID 26149717, PMID 26408225, PMID 28396102, PMID 30904387, PMID 31173898, PMID 31260802, PMID 32416453, PMID 33811823, PMID 34102349, PMID 34126278, PMID 34260836, PMID 34265047, PMID 34433773, PMID 34773261, PMID 35235189, PMID 35689489, PMID 35781099, PMID 36440464, PMID 36608310, PMID 36791280, PMID 37341189, PMID 37698881, PMID 38696034, PMID 39704205, PMID 40472328, PMID 41871072, PMID 42180389, PMID 5449164, PMID 10387937, PMID 10619108, PMID 10845900, PMID 10845940, PMID 10997973, PMID 11172169, PMID 11222360, PMID 11301861
2016 (11), P30CA015704 (11), 2017 (9), P30CA033572 (9), 2015 (7), 2014 (6), 2019 (6), 2009 (5), 2018 (5), P30CA006973 (5), 2023 (4), P01CA015396 (4), P30CA068485 (4), U01HL069294 (4), 2025 (3)